KRMD
KORU Medical Systems, Inc. NASDAQ Listed Apr 5, 1994$3.90
+0.52%
vs $3.88
Mkt Cap $179.1M
52w Low $2.91
26.8% of range
52w High $6.61
50d MA $4.07
200d MA $4.57
P/E (TTM)
-68.3x
EV/EBITDA
—
P/B
10.6x
Debt/Equity
0.2x
ROE
-15.5%
P/FCF
-383.2x
RSI (14)
41.80
ATR (14)
$0.15
Beta
0.54
50d MA
$4.07
200d MA
$4.57
Avg Volume
135.3K
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
24 Carpenter Road · Mahwah, NY 10918 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | -0.02 | -0.02 | +0.0% | 4.01 | +12.0% | +10.7% | -5.4% | -4.3% | -0.5% | -3.8% | — |
| Mar 12, 2026 | AMC | -0.02 | -0.01 | +50.0% | 4.31 | +0.0% | -0.7% | +0.2% | -0.5% | +1.9% | -1.1% | — |
| Nov 12, 2025 | AMC | -0.03 | -0.02 | +33.3% | 3.78 | +5.8% | +15.1% | -0.7% | +3.9% | -0.4% | -2.7% | — |
| Aug 6, 2025 | AMC | -0.03 | 0.01 | +133.3% | 3.26 | +4.6% | +18.7% | +2.3% | +2.0% | +2.7% | +3.6% | — |
| May 7, 2025 | AMC | -0.02 | -0.03 | -50.0% | 2.72 | +8.5% | +21.0% | -4.3% | +3.2% | -1.2% | -6.2% | — |
| Mar 12, 2025 | AMC | -0.03 | -0.03 | +0.0% | 3.28 | -4.0% | -17.7% | +2.6% | +7.2% | -2.4% | +0.7% | — |
| Nov 13, 2024 | AMC | -0.02 | -0.03 | -21.0% | 3.20 | +6.2% | -3.8% | +2.9% | -0.6% | +5.1% | +10.3% | — |
| Aug 7, 2024 | AMC | -0.01 | -0.02 | -52.6% | 2.13 | +15.5% | +16.4% | +2.4% | -3.1% | -3.7% | -2.5% | — |
| May 1, 2024 | AMC | -0.01 | -0.02 | -47.2% | 2.25 | +0.9% | +5.8% | -2.5% | -0.4% | -2.2% | -0.4% | — |
| Mar 13, 2024 | AMC | -0.02 | -0.02 | -25.0% | 2.12 | +3.8% | +3.3% | +0.5% | -5.5% | -1.0% | +11.7% | — |
| Nov 8, 2023 | AMC | -0.02 | -0.03 | -40.1% | 2.19 | -3.7% | -7.3% | +5.4% | -0.9% | +8.5% | -5.7% | — |
| Aug 9, 2023 | AMC | -0.05 | -0.05 | +0.0% | 2.37 | -4.6% | +4.2% | +1.6% | +2.4% | -0.8% | +1.2% | — |
| May 4, 2023 | AMC | -0.04 | -0.05 | -25.0% | 4.06 | -3.9% | -1.2% | -2.2% | -2.8% | +2.1% | +1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 | B. Riley Securities | Maintains | Buy → Buy | — | $4.31 | $4.31 | +0.0% | -0.7% | +0.2% | -0.5% | +1.9% | -1.1% |
| Mar 13 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.31 | $4.31 | +0.0% | -0.7% | +0.2% | -0.5% | +1.9% | -1.1% |
| Dec 22 | Lake Street | Maintains | Buy → Buy | — | $5.80 | $5.93 | +2.2% | +4.7% | +7.4% | -0.6% | -3.9% | -2.7% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $5.77 | $5.79 | +0.3% | -4.5% | +4.4% | +0.9% | +4.7% | +7.4% |
| Aug 7 | Piper Sandler | Maintains | Neutral → Neutral | — | $3.26 | $3.41 | +4.6% | +18.7% | +2.3% | +2.0% | +2.7% | +3.6% |
| May 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $2.72 | $2.95 | +8.5% | +21.0% | -4.3% | +3.2% | -1.2% | -6.2% |
| Feb 14 | Piper Sandler | Downgrade | Overweight → Neutral | — | $4.75 | $4.50 | -5.3% | -8.0% | -5.0% | -3.6% | -3.0% | -4.4% |
| Jan 17 | Craig-Hallum | Maintains | Buy → Buy | — | $4.00 | $4.08 | +2.0% | +2.2% | +1.2% | -1.2% | +0.2% | +0.5% |
| Jan 14 | Lake Street | Maintains | Buy → Buy | — | $3.95 | $4.06 | +2.8% | +3.0% | -3.2% | +1.5% | +2.2% | +1.2% |
| Nov 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $3.20 | $3.40 | +6.2% | -3.8% | +2.9% | -0.6% | +5.1% | +10.3% |
| Nov 14 | Craig-Hallum | Maintains | Buy → Buy | — | $3.20 | $3.40 | +6.2% | -3.8% | +2.9% | -0.6% | +5.1% | +10.3% |
| Nov 14 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.20 | $3.40 | +6.2% | -3.8% | +2.9% | -0.6% | +5.1% | +10.3% |
| Aug 8 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.13 | $2.46 | +15.5% | +16.4% | +2.4% | -3.1% | -3.7% | -2.5% |
| Mar 14 | B. Riley Securities | Maintains | Buy → Buy | — | $2.12 | $2.20 | +3.8% | +3.3% | +0.5% | -5.5% | -1.0% | +11.7% |
| Dec 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $2.28 | $2.29 | +0.4% | +3.5% | +0.8% | -3.4% | +0.9% | +3.4% |
| Aug 3 | Piper Sandler | Maintains | Overweight → Overweight | — | $2.48 | $2.47 | -0.4% | +2.8% | -0.8% | -2.8% | -0.8% | -2.9% |
| Jan 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $3.70 | $3.82 | +3.2% | +3.2% | +3.4% | +3.8% | -2.0% | +0.2% |
| Nov 10 | Piper Sandler | Upgrade | Neutral → Overweight | — | $2.31 | $2.47 | +6.9% | +16.9% | +10.0% | -1.7% | +0.0% | -4.1% |
| Nov 10 | Canaccord Genuity | Upgrade | Hold → Buy | — | $2.31 | $2.47 | +6.9% | +16.9% | +10.0% | -1.7% | +0.0% | -4.1% |
| Jan 26 | Piper Sandler | Downgrade | Overweight → Neutral | — | $5.13 | $4.19 | -18.3% | -15.6% | -2.1% | -2.6% | -2.2% | -0.7% |
| Jan 26 | Canaccord Genuity | Downgrade | Buy → Hold | — | $5.13 | $4.19 | -18.3% | -15.6% | -2.1% | -2.6% | -2.2% | -0.7% |
| Nov 5 | Canaccord Genuity | Maintains | Buy → Buy | — | $4.16 | $4.18 | +0.5% | -2.4% | -2.0% | -4.0% | +0.3% | +1.8% |
| Jul 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $9.49 | $9.79 | +3.2% | +3.7% | +2.5% | -2.0% | -0.3% | -1.6% |
| Jun 24 | Piper Sandler | Maintains | Overweight → Overweight | — | $8.98 | $9.32 | +3.8% | +3.3% | -0.1% | -7.3% | +2.7% | +1.8% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | KALBERMATTEN ADAM ROff | President-Chief Commercial Off | Buy | 7,500 | $3.93 | $29K | 312,500 | +1.81% | — |
| Jun 11, 2026 | KALBERMATTEN ADAM ROff | President-Chief Commercial Off | Buy | 5,000 | $3.96 | $20K | 305,000 | +1.81% | — |
| May 18, 2026 | Schiller EricOff | Chief Technology Officer | Buy | 5,000 | $3.91 | $20K | 5,000 | +3.50% | +0.72% |
| May 15, 2026 | Tharby Linda MDir/Off | Chief Executive Officer | Buy | 1,191 | $3.92 | $5K | 620,622 | +3.50% | +0.72% |
| May 15, 2026 | Tharby Linda MDir/Off | Chief Executive Officer | Buy | 1,191 | $1191.00 | $1.4M | 620,622 | +3.50% | +0.72% |
| May 14, 2026 | Pazdan ChristopherOff | Chief Operating Officer | Buy | 5,000 | $3.88 | $19K | 305,131 | +3.39% | +2.44% |
| May 14, 2026 | Adams Thomas EdwardOff | Chief Financial Officer | Buy | 459 | $3.90 | $2K | 308,147 | +3.39% | +2.44% |
| May 14, 2026 | Adams Thomas EdwardOff | Chief Financial Officer | Buy | 5,041 | $3.86 | $19K | 307,688 | +3.39% | +2.44% |
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
KRMD signed a material agreement with HSBC Ventures USA Inc., signaling potential strategic partnership, funding, or technology collaboration that could accelerate growth and validate the business model.
Apr 3
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
KRMD's CEO departure effective year-end 2026 signals potential leadership transition uncertainty, which investors should monitor for strategic direction changes and management capability concerns.
Mar 16
8-K
Unknown — 8-K Filing
Kermed appears to be restructuring operations while excluding significant non-cash items from profitability metrics, suggesting management expects near-term losses but wants investors focused on operational cash generation potential.
Mar 12
8-K · 5.03
! Medium
KORU Medical Systems, Inc. -- 8-K 5.03: Amendment to Articles / Bylaws
KORU Medical Systems changed its fiscal year end, which may affect financial reporting schedules and investor timing for earnings announcements and tax planning.
Feb 11
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 1,686,224 | $7M | New | Mar 2026 |
| 2 | Morgan Stanley | 854,052 | $5M | Added | Dec 2025 |
| 3 | Simcoe Capital Llc | 811,247 | $4M | Added | Mar 2026 |
| 4 | Meros Investment Management, Lp | 760,451 | $3M | Reduced | Mar 2026 |
| 5 | Empire Financial Management Company, Llc | 703,139 | $3M | New | Mar 2026 |
| 6 | Archon Capital Management Llc | 642,923 | $3M | Added | Mar 2026 |
| 7 | Russell Investments Group, Ltd. | 423,419 | $2M | Added | Mar 2026 |
| 8 | Northern Trust Corp | 322,252 | $1M | Added | Mar 2026 |
| 9 | Vanguard Portfolio Management Llc | 255,455 | $1M | New | Mar 2026 |
| 10 | Royal Bank Of Canada | 235,804 | $1M | Added | Mar 2026 |
| 11 | Albion Financial Group /ut | 216,374 | $935K | — | Mar 2026 |
| 12 | Connor, Clark & Lunn Investment Management Ltd. | 138,512 | $805K | Added | Dec 2025 |
| 13 | Qube Research & Technologies Ltd | 179,014 | $773K | New | Mar 2026 |
| 14 | Highmark Wealth Management Llc | 120,935 | $522K | — | Mar 2026 |
| 15 | Calamos Advisors Llc | 80,961 | $470K | Added | Dec 2025 |
| 16 | Pnc Financial Services Group, Inc. | 97,005 | $419K | — | Mar 2026 |
| 17 | Sei Investments Co | 93,772 | $405K | Added | Mar 2026 |
| 18 | Two Sigma Investments, Lp | 91,645 | $396K | Added | Mar 2026 |
| 19 | Bank Of New York Mellon Corp | 79,576 | $344K | Reduced | Mar 2026 |
| 20 | Informed Momentum Co Llc | 77,013 | $333K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$179.1M
Enterprise Value
$174.2M
P/E (TTM)
-68.30x
Forward P/E
—
PEG Ratio
1.81x
P/B
10.57x
P/S
4.38x
P/FCF
-383.16x
EV/EBITDA
—
Shares Out
46.2M
Financials (TTM)
Revenue
$41.1M
Net Income
-$2.6M
EBITDA
-$2.2M
Free Cash Flow
-$470K
Op Cash Flow
$462K
EPS Basic
$-0.06
EPS Diluted
$-0.06
EPS Forward
$-0.03
Gross Margin
60.3%
Op Margin
-7.2%
Net Margin
-6.4%
Balance Sheet
Total Assets
$28.2M
Total Liab.
$11.2M
Total Equity
$17.0M
Cash
$8.9M
LT Debt
$3.0M
Book Value/Sh
$0.37
Debt/Equity
0.21x
Current Ratio
2.44
Quick Ratio
1.99
Returns & Growth
ROE
-15.5%
ROA
-9.3%
ROIC
-14.5%
Rev Growth YoY
+22.2%
EPS Growth YoY
+56.1%
Price Returns
2W
+2.0%
1M
+1.8%
3M
-14.9%
6M
-31.4%
12M
+50.4%
Technicals
52W High
$6.61
52W Low
$2.91
50d MA
$4.07
200d MA
$4.57
RSI (14)
41.80
ATR (14)
$0.15
Beta
0.54
Avg Volume
135K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$7.00
High
$8.00
Low
$6.00
Median
$7.00
Data updated apr 25, 2026 5:59pm
· Source: financialmodelingprep.com